efficacy of bevacizumab in patients with metastatic colorectal cancer. Comprehensive molecular analysis to predict the efficacy of bevacizumab in patients with metastatic colorectal cancer

• Not all patients with CRC showed clinical improvements with bevacizumab treatment. • A specific subset of patients with CRC may significantly benefit from bevacizumab treatment. • A personalized therapeutic approach in CRC is feasible.